A review of minimally invasive cosmetic procedures

British Journal of Dermatology

Volumn 159, Issue 5, 2008, Pages 1036-1050

  Ogden, S ^a   Griffiths, T W ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MACCLESFIELD DISTRICT GENERAL HOSPITAL   (United Kingdom)

Author keywords

Botulinum toxin; Intradermal fillers; Peels; Photoageing; Wrinkles

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; COLLAGEN; DERMATOLOGICAL AGENT; FILLER; HYALURONIC ACID; JESSNER SOLUTION; NEURONOX; PHENOL; POLY(METHYL METHACRYLATE); PURETOX; PYRUVIC ACID; RELOXIN; SALICYLIC ACID; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG;

AGING; CHLOASMA; CLINICAL TRIAL; CUTANEOUS PARAMETERS; DRY EYE; DYSTONIA; EDEMA; ERYTHEMA; ESTHETIC SURGERY; FLU LIKE SYNDROME; HEADACHE; HOLISTIC CARE; HUMAN; KERATITIS; LAGOPHTHALMOS; LASER SURGERY; LIGHT DAMAGE; MALAISE; MINIMALLY INVASIVE SURGERY; NAUSEA; OUTPATIENT; PAIN; PRIORITY JOURNAL; PTOSIS; RASH; REJUVENATION; RESPIRATORY TRACT INFECTION; REVIEW; SKIN ABRASION; WRINKLE;

BIOCOMPATIBLE MATERIALS; BOTULINUM TOXINS; CHEMEXFOLIATION; COSMETIC TECHNIQUES; FACE; HUMANS; INJECTIONS, INTRADERMAL; PATIENT SATISFACTION; REJUVENATION; SKIN AGING; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 54349095927     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08845.x     Document Type: Review

References (87)

1. Donofrio L. Fat distribution: a morphologic study of the aging face. Dermatol Surg 2000 26 : 1107 12.
2. Buss DM. The Evolution of Desire: Strategies of Human Mating. New York : Basic Books, 1994.
3. Finn JC, Cox SE, Earl ML. Social implications of hyperdynamic lines. Dermatol Surg 2003 29 : 450 5.
4. Kowalski J, Ravelo A, Saulay M, Fraczek S. Patient self-perceptions and satisfaction with botulinum toxin type-A treatment for moderate to severe crow's feet: results from a placebo-controlled clinical study. Presented at the American Academy of Dermatology 2005 Mtg Book 87 (ABS-137).
5. American Society for Aesthetic Plastic Surgery. 11.5 Million Cosmetic Procedures in 2006. 2007. Available at: http://www.surgery.org/press/news- release.php?iid=465 (last accessed 28 July 2008).
6. Carruthers JA, Lowe NJ, Menter MA et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002 46 : 840 9.
7. Ascher B, Zakine B, Kestemont P et al. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. J Am Acad Dermatol 2004 51 : 223 33.
8. Lowe NJ, Lask G, Yamauchi P, Moore D. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. J Am Acad Dermatol 2002 47 : 834 40.
9. Lowe NJ, Ascher B, Heckmann M et al. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet. Dermatol Surg 2005 31 : 257 62.
10. Carruthers A, Carruthers J, Cohen J. A prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in female subjects with horizontal forehead rhytides. Dermatol Surg 2003 29 : 461 7.
11. Carruthers A, Carruthers J, Said S. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. Dermatol Surg 2005 31 : 414 22.
12. Carruthers A, Carruthers J. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin A in men with glabellar rhytids. Dermatol Surg 2005 31 : 1297 303.
13. Monheit G, Carruthers A, Brandt F, Rand R. A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose. Dermatol Surg 2007 33 : S51 9.
14. Rzany B, Ascher B, Fratila A et al. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region. Arch Dermatol 2006 142 : 320 6.
15. Lowe P, Patnaik R, Lowe N. Comparison of two formulations of botulinum toxin A for the treatment of glabellar lines: a double-blind, randomized study. J Am Acad Dermatol 2006 55 : 975 80.
16. Carruthers A, Carruthers J, Flynn TC, Leong M. Dose-finding, safety and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines. Dermatol Surg 2007 33 : S60 8.
17. Flynn TC, Carruthers J, Carruthers AJ, Clark RE. Botulinum A toxin (Botox) in the lower eyelid: dose-finding study. Dermatol Surg 2003 29 : 943 51.
18. Lowe NJ, Yamauchi PS. Cosmetic uses of botulinum toxins for lower aspects of the face and neck. Clin Dermatol 2004 22 : 18 22.
19. Lowe NJ, Yamauchi PS, Lask GP et al. Botulinum toxins type A and B for brow furrows: preliminary experiences with type B toxin dosing. J Cosmet Laser Ther 2002 4 : 15 18.
20. Matarasso SL. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides. Dermatol Surg 2003 29 : 7 13.
21. Baumann L, Slezinger A, Vujevich J et al. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial. Dermatol Surg 2003 29 : 508 15.
22. Yamauchi PS, Lowe NJ. Botulinum toxins type A and B: comparison of efficacy, duration, and dose ranging studies for the treatment of facial rhytides and hyperhidrosis. Clin Dermatol 2004 22 : 34 9.
23. Carruthers J, Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg 2003 29 : 802 9.
24. Batra RS, Dover JS, Arndt KA. Adverse event reporting for botulinum toxin type A. J Am Acad Dermatol 2005 53 : 1080 2.
25. Klein AW. Contraindications and complications with the use of botulinum toxin. Clin Dermatol 2004 22 : 66 75.
26. Wollina U, Konrad H. Managing adverse effects associated with botulinum toxin type A: a focus on cosmetic procedures. Am J Clin Dermatol 2005 6 : 141 50.
27. Alam M, Arndt KA, Dover JS. Severe, intractable headache after injection with botulinum A exotoxin: report of 5 cases. J Am Acad Dermatol 2002 46 : 62 5.
28. Northington ME, Huang CC. Dry eyes and superficial punctate keratitis: a complication of treatment of glabellar dynamic rhytides with botulinum exotoxin A. Dermatol Surg 2004 30 : 1515 17.
29. Cox SE, Finn JC, Stetler L et al. Development of the facial lines treatment satisfaction questionnaire and the initial results for botulinum toxin type A-treated patients. Dermatol Surg 2003 29 : 444 9.
30. Sommer B, Zschocke I, Bergfeld D et al. Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines. Dermatol Surg 2003 29 : 456 60.
31. Carruthers A, Carruthers J, Dessain A. Preliminary results with the facial lines outcomes questionnaire in the treatment of multiple upper facial rhytids with botulinum toxin type A: results from a single center, dose comparison, pilot study. Presented at the American Academy of Dermatology 2005 Mtg Book 88 (ABS-138).
32. Carruthers J, Carruthers A. Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes. Dermatol Surg 2007 33 : S10 17.
33. Fagien S, Cox SE, Finn JC et al. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study. Dermatol Surg 2007 33 : S2 9.
34. Carruthers J, Carruthers A. Procedures in Cosmetic Dermatology: Soft Tissue Augmentation. Philadelphia : Saunders, 2005.
35. Klein AW. Techniques for soft tissue augmentation: an 'A to Z'. Am J Clin Dermatol 2006 7 : 107 20.
36. Matarasso SL, Carruthers JD, Jewell ML Resylane Consensus Group. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg 2006 117 (Suppl. 3 3 34.
37. Bauman L. CosmoDerm/CosmoPlast (human bioengineered collagen) for the aging face. Facial Plast Surg 2004 20 : 125 8.
38. Sclafani AP, Romo T III. Collagen, human collagen, and fat: the search for a three-dimensional soft tissue filler. Facial Plast Surg 2001 17 : 79 85.
39. Stolman LP. Human collagen reactions. Dermatol Surg 2005 31 : 1634.
40. Sclafani AP, Romo T III., Jaconi AA. Rejuvenation of the aging lip with an injectable acellular dermal graft (Cymetra). Arch Facial Plast Surg 2002 4 : 252 7.
41. Struck H. Immunological investigations of antigenicity and specificity of soluble collagen fractions. IV. Anaphylaxis and allergy experiments. Eur Surg Res 1976 8 : 243 9.
42. Monstrey SJ, Pitaru S, Hamdi M et al. A two-stage phase I trial of Evolence30 collagen for soft-tissue contour correction. Plast Reconstr Surg 2007 120 : 303 11.
43. Narins RS, Brandt FS, Lorenc ZP et al. A randomized, multicenter study of the safety and efficacy of Dermicol-P35 and non-animal-stabilized hyaluronic acid gel for the correction of nasolabial folds. Dermatol Surg 2007 33 : S213 21.
44. Lowe NL, Maxwell CA, Lowe P et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol 2001 45 : 930 3.
45. McCracken MS, Khan JA, Wulc AE et al. Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. Ophthal Plast Reconstr Surg 2006 22 : 188 91.
46. Narins RS, Brandt F, Leyden J. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003 29 : 588 95.
47. Baumann LS, Shamban AT, Lupo MP et al. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study. Dermatol Surg 2007 33 : S128 35.
48. Lindqvist C, Tveten S, Bondevik BE, Fagrell D. A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds. Plast Reconstr Surg 2005 115 : 282 9.
49. Wang F, Garza LA, Kang S et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol 2007 143 : 155 63.
50. Monheit G, Coleman KM. Hyaluronic acid fillers. Dermatol Ther 2006 19 : 141 50.
51. Beer K. A randomized, evaluator blinded comparison of efficacy of hyaluronic acid gel and avian-sourced Hylan B Plus gel for correction of nasolabial folds. Dermatol Surg 2007 33 : 928 36.
52. Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002 28 : 491 4.
53. Cohen SR, Holmes RE. Artecoll: a long-lasting injectable wrinkle filler material: report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 2004 114 : 964 76.
54. Cohen SR, Berner CF, Busso M et al. Artefill: a long-lasting injectable wrinkle filler material - summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes. Plast Reconstr Surg 2006 118 (Suppl. 3 S64 76.
55. Klein AW. Soft tissue augmentation 2006: filler fantasy. Dermatol Ther 2006 19 : 129 33.
56. Bergeret-Galley C, Latouche X, Illouz Y-G. The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep. Aesthetic Plast Surg 2001 25 : 249 55.
57. Angus JE, Affleck AG, Leach IH, Millard LG. Two cases of delayed granulomatous reactions to the cosmetic filler Dermalive, a hyaluronic acid and acrylic hydrogel. Br J Dermatol 2006 155 : 1077 8.
58. Jansen DA, Graivier MH. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg 2006 118 : S22 30.
59. Jacovella PF, Peiretti CB, Cunille D et al. Long-lasting results with hydroxylapatite (Radiesse) facial filler. Plast Reconstr Surg 2006 118 : S15 21.
60. Silvers SL, Eviatar JA, Echavez MI, Pappas AL. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus associated lipoatrophy: one year durability. Plast Reconstr Surg 2006 118 : S34 45.
61. Smith S, Busso M, McClaren M, Bass LS. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds. Dermatol Surg 2007 33 : S112 21.
62. Moers-Carpi M, Vogt S, Santos BM et al. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg 2007 33 : S144 51.
63. Roy D, Sadick N, Mangat D. Clinical trial of a novel filler material for soft tissue augmentation of the face containing synthetic calcium hydroxylapatite microspheres. Dermatol Surg 2006 32 : 1134 9.
64. Kanchwala SK, Holloway L, Bucky LP. Reliable soft tissue augmentation. A clinical comparison of injectable soft tissue fillers for facial-volume augmentation. Ann Plast Surg 2005 55 : 30 5.
65. Woerle B, Hanke CW, Sattler G. Poly-l-lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol 2004 3 : 385 9.
66. Narins RS, Beer K. Liquid injectable silicone: a review of its history, immunology, technical considerations, complications, and potential. Plast Reconstr Surg 2006 118 : S77 84.
67. Duffy DM. Liquid silicone for soft tissue augmentation. Dermatol Surg 2005 31 : 1530 41.
68. Jones DH, Carruthers A, Orentreich D et al. Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: an open pilot trial. Dermatol Surg 2004 30 : 1279 86.
69. Zakapoulu N, Kontochristopoulos MD, Kontochristopoulos G. Superficial chemical peels. J Cosmet Dermatol 2006 5 : 246 53.
70. Landau M. Combination of chemical peelings with botulinum toxin injections and dermal fillers. J Cosmet Dermatol 2006 5 : 121 6.
71. Butler PE, Gonzalez S, Randolph MA et al. Quantitative and qualitative effects of chemical peeling on photo-aged skin: an experimental study. Plast Reconstr Surg 2001 107 : 222 8.
72. Brody HJ. Complications of chemical resurfacing. Dermatol Clin 2001 19 : 427 38.
73. Bernstein EF, Lee J, Brown DB et al. Glycolic acid treatment increases type I collagen mRNA and hyaluronic acid content of human skin. Dermatol Surg 2001 27 : 429 33.
74. Newman N, Newman A, Moy LS et al. Clinical improvement of photoaged skin with 50% glycolic acid. A double-blind vehicle-controlled study. Dermatol Surg 1996 22 : 455 60.
75. Bernstein EF. Chemical peels. Semin Cutan Med Surg 2002 21 : 27 45.
76. Kligman D, Kligman AM. Salicylic acid peels for the treatment of photoaging. Dermatol Surg 1998 24 : 325 8.
77. Otley CC, Roenigk RK. Medium-depth chemical peeling. Semin Cutan Med Surg 1996 15 : 145 54.
78. Humphreys TR, Werth V, Dzubow L, Kligman A. Treatment of photodamaged skin with trichloroacetic acid and topical tretinoin. J Am Acad Dermatol 1996 34 : 638 44.
79. Tse Y, Ostad A, Lee HS et al. A clinical and histologic evaluation of two medium-depth peels. Glycolic acid versus Jessner's trichloroacetic acid. Dermatol Surg 1996 22 : 781 6.
80. Reed JT, Joseph AK, Bridenstine JB. Treatment of periorbital wrinkles. A comparison of the SilkTouch carbon dioxide laser with a medium-depth chemical peel. Dermatol Surg 1997 23 : 643 8.
81. Ghersetich I, Brazzini B, Peris K et al. Pyruvic acid peels for the treatment of photoaging. Dermatol Surg 2004 30 : 32 6.
82. Berardesca E, Cameli N, Primavera G, Carrera M. Clinical and instrumental evaluation of skin improvement after treatment with a new 50% pyruvic acid peel. Dermatol Surg 2006 32 : 526 31.
83. Matarasso SL, Brody HJ. Deep chemical peeling. Semin Cutan Med Surg 1996 15 : 155 61.
84. Stone PA. The use of modified phenol for chemical face peeling. Clin Plast Surg 1998 25 : 21 44.
85. Moy LS, Kotler R, Lesser T. The histologic evaluation of pulsed carbon dioxide laser resurfacing versus phenol chemical peels in vivo. Dermatol Surg 1999 25 : 597 600.
86. Hetter GP. An examination of the phenol-croton oil peel: part IV. Face peel results with different concentrations of phenol and croton oil. Plast Reconstr Surg 2000 105 : 1061 83.
87. Chew J, Gin I, Rau KA et al. Treatment of upper lip wrinkles: a comparison of 950 microsec dwell time carbon dioxide laser with unoccluded Baker's phenol chemical peel. Dermatol Surg 1999 25 : 262 6.